<VariationArchive VariationID="1071013" VariationName="NC_000013.10:g.(?_48937921)_(48942750_?)del" VariationType="Deletion" Accession="VCV001071013" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057632" VariationID="1071013">
      <GeneList>
        <Gene Symbol="RB1" FullName="RB transcriptional corepressor 1" GeneID="5925" HGNC_ID="HGNC:9884" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="48303751" stop="48481890" display_start="48303751" display_stop="48481890" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="48877882" stop="49056025" display_start="48877882" display_stop="49056025" Strand="+" />
          </Location>
          <OMIM>614041</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RB1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000013.10:g.(?_48937921)_(48942750_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" innerStart="48937921" innerStop="48942750" display_start="48937921" display_stop="48942750" variantLength="4830" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.(?_48937921)_(48942750_?)del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.(?_48937921)_(48942750_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000013.10:g.(?_48937921)_(48942750_?)del AND Retinoblastoma" Accession="RCV001383353" Version="5">
        <ClassifiedConditionList TraitSetID="3557">
          <ClassifiedCondition DB="MedGen" ID="C0035335">Retinoblastoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-06-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-06-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17096365</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3557" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6463" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinoblastoma</ElementValue>
                <XRef ID="2161" DB="GeneTests" />
                <XRef ID="Retinoblastoma/6282" DB="Genetic Alliance" />
                <XRef ID="HP:0009919" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008380" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RETINOBLASTOMA, SOMATIC</ElementValue>
                <XRef Type="Allelic variant" ID="614041.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614041.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Eye cancer, retinoblastoma</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RB1</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RB</ElementValue>
                <XRef Type="MIM" ID="180200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors.</Attribute>
                <XRef ID="NBK1452" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7563" />
                <XRef ID="7563" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000521663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520069" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518780" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000597429" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528909" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500594" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502480" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502581" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521639" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000333054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500108" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529017" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553202" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000324949" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522559" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502479" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Both sporadic and heritable forms are tested.</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301625</ID>
                <ID Source="BookShelf">NBK1452</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 1995">
                <ID Source="pmc">1801355</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">3061998</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASHG/ACMG, 2015">
                <ID Source="PubMed">26140447</ID>
                <ID Source="pmc">4570999</ID>
              </Citation>
              <XRef ID="790" DB="Orphanet" />
              <XRef ID="C0035335" DB="MedGen" />
              <XRef ID="D012175" DB="MeSH" />
              <XRef ID="MONDO:0008380" DB="MONDO" />
              <XRef Type="MIM" ID="180200" DB="OMIM" />
              <XRef Type="primary" ID="HP:0009919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3108074" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000321.2_13_Deletion (exons 9-11)|MedGen:C0035335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582452" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17096365</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant has not been reported in the literature in individuals with RB1-related conditions. This variant is an out-of-frame deletion of the genomic region encompassing exon(s) 9-11 of the RB1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.(?_48937921)_(48942750_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0035335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3108074" TraitType="Disease" MappingType="XRef" MappingValue="C0035335" MappingRef="MedGen">
        <MedGen CUI="C0035335" Name="Retinoblastoma" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

